Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study
Conclusions/interpretationMR-proADM is a prognostic biomarker for heart failure in people with type 2 diabetes but gives no significant complementary information on prediction of heart failure compared with NT-proBNP.
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Cardiology | Congestive Heart Failure | Coronary Heart Disease | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Disease | Heart Failure | Proteinuria | Study | Women